Edition:
United Kingdom

BiondVax Pharmaceuticals Ltd (BVXV.OQ)

BVXV.OQ on NASDAQ Stock Exchange Capital Market

5.02USD
15 Dec 2017
Change (% chg)

$0.03 (+0.60%)
Prev Close
$4.99
Open
$4.95
Day's High
$5.06
Day's Low
$4.95
Volume
204
Avg. Vol
6,741
52-wk High
$10.75
52-wk Low
$3.04

Latest Key Developments (Source: Significant Developments)

Biondvax Pharmaceuticals Ltd Reports Qtrly Loss Per Share of NIS 0.01 ‍​
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Biondvax Pharmaceuticals Ltd ::BIONDVAX PHARMACEUTICALS LTD - QTRLY LOSS PER SHARE NIS 0.01 ‍​.  Full Article

BiondVax and NIH sign clinical trial agreement for phase 2 trial for universal flu vaccine
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Biondvax Pharmaceuticals Ltd :BiondVax and NIH sign clinical trial agreement for a phase 2 trial in the U.S. with BiondVax's universal flu vaccine.BiondVax Pharmaceuticals - ‍NIAID is submitting IND to FDA, participant recruitment anticipated to begin after end of 2017/18 flu season​.  Full Article

Biondvax Pharmac files for stock shelf of up to $150 mln
Friday, 4 Nov 2016 

Biondvax Pharmaceuticals Ltd :Biondvax pharmaceuticals ltd - files for stock shelf of up to $150 million - sec filing.  Full Article

Biondvax reports Q2 loss per share NIS 0.02
Thursday, 18 Aug 2016 

Biondvax Pharmaceuticals Ltd : Announces second quarter 2016 financial results and update .Qtrly loss per share NIS 0.02.  Full Article

BRIEF-Biondvax Pharmaceuticals Ltd Reports Qtrly Loss Per Share of NIS 0.01 ‍​

* BIONDVAX PHARMACEUTICALS LTD - QTRLY LOSS PER SHARE NIS 0.01 ‍​ Source text for Eikon: Further company coverage: